One more study described the use of a magneto-fluorescent theranostic nanocomplex targeted to neutrophil gelatinase-associated lipocalin (NGAL) for imaging and treatment of pancreatic cancer [162]. The gene discussed is LCN2; the disease is familial pancreatic carcinoma.